Researchers are piloting a new drug development pathway for the treatment of multiple sclerosis, asthma
Mutant peptides derived from SARS-CoV-2 inhibit the ability of T cells to recognize and destroy infectious cells
The new publication Nature Communication by Mann & Theis Groups capitalizes on the benefits of large-scale peptide cross-sectional (CCS) measurements and in-depth learning for 4D-proteomics